annual CFI:
$121.41M+$342.52M(+154.91%)Summary
- As of today (August 29, 2025), ABCL annual cash flow from investing activities is $121.41 million, with the most recent change of +$342.52 million (+154.91%) on December 31, 2024.
- During the last 3 years, ABCL annual CFI has risen by +$453.66 million (+136.54%).
- ABCL annual CFI is now at all-time high.
Performance
ABCL Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$32.25M-$40.18M(-506.39%)Summary
- As of today (August 29, 2025), ABCL quarterly cash flow from investing activities is -$32.25 million, with the most recent change of -$40.18 million (-506.39%) on June 1, 2025.
- Over the past year, ABCL quarterly CFI has dropped by -$83.76 million (-162.59%).
- ABCL quarterly CFI is now -162.59% below its all-time high of $51.52 million, reached on June 30, 2024.
Performance
ABCL quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$13.20M-$83.76M(-86.39%)Summary
- As of today (August 29, 2025), ABCL TTM cash flow from investing activities is $13.20 million, with the most recent change of -$83.76 million (-86.39%) on June 1, 2025.
- Over the past year, ABCL TTM CFI has dropped by -$33.77 million (-71.90%).
- ABCL TTM CFI is now -88.90% below its all-time high of $118.94 million, reached on December 31, 2024.
Performance
ABCL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ABCL Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +154.9% | -162.6% | -71.9% |
| 3 y3 years | +136.5% | -19.5% | +104.1% |
| 5 y5 years | +2200.5% | -1413.9% | +271.1% |
ABCL Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +134.4% | -162.6% | +88.3% | -88.9% | +102.8% |
| 5 y | 5-year | at high | +134.4% | -162.6% | +88.3% | -88.9% | +102.8% |
| alltime | all time | at high | +134.4% | -162.6% | +88.3% | -88.9% | +102.8% |
ABCL Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$32.25M(-506.4%) | $13.20M(-86.4%) |
| Mar 2025 | - | $7.93M(-76.4%) | $96.96M(-18.5%) |
| Dec 2024 | $121.41M(-154.9%) | $33.56M(+750.9%) | $118.94M(+86.2%) |
| Sep 2024 | - | $3.94M(-92.3%) | $63.88M(+36.0%) |
| Jun 2024 | - | $51.52M(+72.2%) | $46.97M(-218.6%) |
| Mar 2024 | - | $29.91M(-239.2%) | -$39.59M(-81.9%) |
| Dec 2023 | -$221.11M(-37.3%) | -$21.49M(+65.8%) | -$219.11M(+6.3%) |
| Sep 2023 | - | -$12.96M(-63.0%) | -$206.14M(-56.1%) |
| Jun 2023 | - | -$35.04M(-76.6%) | -$469.44M(+1.7%) |
| Mar 2023 | - | -$149.61M(+1655.4%) | -$461.38M(+36.4%) |
| Dec 2022 | -$352.63M | -$8.52M(-96.9%) | -$338.14M(+2.3%) |
| Sep 2022 | - | -$276.27M(+923.9%) | -$330.43M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$26.98M(+2.3%) | -$321.36M(-5.8%) |
| Mar 2022 | - | -$26.37M(+3136.9%) | -$340.97M(+3.2%) |
| Dec 2021 | -$332.25M(+177.4%) | -$814.70K(-99.7%) | -$330.44M(-25.1%) |
| Sep 2021 | - | -$267.19M(+473.5%) | -$441.16M(+147.7%) |
| Jun 2021 | - | -$46.59M(+194.1%) | -$178.12M(+33.3%) |
| Mar 2021 | - | -$15.84M(-85.8%) | -$133.66M(+8.3%) |
| Dec 2020 | -$119.78M(+1972.3%) | -$111.54M(+2585.1%) | -$123.41M(+939.9%) |
| Sep 2020 | - | -$4.15M(+95.0%) | -$11.87M(+53.9%) |
| Jun 2020 | - | -$2.13M(-61.8%) | -$7.71M(+38.2%) |
| Mar 2020 | - | -$5.58M | -$5.58M |
| Dec 2019 | -$5.78M(+8.9%) | - | - |
| Dec 2018 | -$5.31M | - | - |
FAQ
- What is AbCellera Biologics Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual CFI year-on-year change?
- What is AbCellera Biologics Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly CFI year-on-year change?
- What is AbCellera Biologics Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM CFI year-on-year change?
What is AbCellera Biologics Inc. annual cash flow from investing activities?
The current annual CFI of ABCL is $121.41M
What is the all time high annual CFI for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual cash flow from investing activities is $121.41M
What is AbCellera Biologics Inc. annual CFI year-on-year change?
Over the past year, ABCL annual cash flow from investing activities has changed by +$342.52M (+154.91%)
What is AbCellera Biologics Inc. quarterly cash flow from investing activities?
The current quarterly CFI of ABCL is -$32.25M
What is the all time high quarterly CFI for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly cash flow from investing activities is $51.52M
What is AbCellera Biologics Inc. quarterly CFI year-on-year change?
Over the past year, ABCL quarterly cash flow from investing activities has changed by -$83.76M (-162.59%)
What is AbCellera Biologics Inc. TTM cash flow from investing activities?
The current TTM CFI of ABCL is $13.20M
What is the all time high TTM CFI for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM cash flow from investing activities is $118.94M
What is AbCellera Biologics Inc. TTM CFI year-on-year change?
Over the past year, ABCL TTM cash flow from investing activities has changed by -$33.77M (-71.90%)